EyeGate completes direct public offering

EyeGate Pharmaceuticals Inc. (NASDAQ:EYEG), Waltham, Mass. Business: Ophthalmic, Transplant Date completed: 2016-06-30 Type: Direct public offering Raised: $3.8 million Shares: 441,000 Price: $2.25 Sh...